01 Jul 2025

Avacta Appoints David Liebowitz, M.D., Ph.D. as Chief Medical Officer and Yulii Bogatyrenko as Advisor in Business Development

Investors | Therapeutics

30 Jun 2025

Appointment of Zeus Capital as Joint Broker to Avacta Group plc

Investors

19 Jun 2025

New Response in the FAP-Dox (AVA6000) Phase 1b Trial

Investors | Therapeutics

09 Jun 2025

Posting of Annual Report and Revised Notice of AGM

Investors

06 Jun 2025

Preliminary Results for the Year Ended December 31, 2024

Investors

04 Jun 2025

Update on timing of preliminary results announcement

Investors

28 May 2025

Board appointments

Investors

27 May 2025

Update on timing of preliminary results announcement

Investors

15 May 2025

Notice of Results

Investors

12 May 2025

Investor Webinar

Investors